The neuropathology of vascular disease in the medical research council cognitive function and ageing study (MRC CFAS)

Current Alzheimer Research

Volumn 9, Issue 6, 2012, Pages 687-696

  Richardson, Kathryn ^a,b   Stephan, Blossom C M ^a   Ince, Paul G ^c   Brayne, Carol ^a   Matthews, Fiona E ^d   Esiri, Margaret M ^e  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d MRC BIOSTATISTICS UNIT   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Angina pectoris; Cardiovascular disease; Dementia; Diabetes mellitus; Hypertension; Myocardial infarction; Neuropathology; Stroke

Indexed keywords

APOLIPOPROTEIN E;

AGING; ALZHEIMER DISEASE; ANGINA PECTORIS; ARTICLE; CEREBROVASCULAR DISEASE; COGNITION; DEMENTIA; DIABETES CONTROL; DISEASE ASSOCIATION; GENOTYPE; HEART INFARCTION; HUMAN; HYPERTENSION; MEDICAL RESEARCH; NEOCORTEX; NEUROPATHOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; SELF REPORT; STROKE; VASCULAR AMYLOIDOSIS; VASCULAR DISEASE;

EID: 84863554633     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720512801322654     Document Type: Article

References (58)

1. Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad Med J 82: 357-362 (2006).
2. Macleod MR, Amarenco P, Davis SM, Donnan GA. Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of stroke. Lancet Neurol 3: 408-414 (2004).
3. Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 331: 1474-1479 (1994).
4. Ganong WF (2003) Review of medical physiology Lange Medical/McGraw Hill, New York; London.
5. Mielke M, Rosenberg P, Tschanz J, Cook L, Corcoran C, Hayden K, et al. Vascular factors predict rate of progression in Alzheimer disease. Neurology 6: 1850-1858 (2007).
6. Raz N, Rodrigue KM. Differential aging of the brain: patterns, cognitive correlates and modifiers. Neurosci Biobehav Rev 30: 730-748 (2006).
7. Mitchell GF. Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol 105: 1652-1660 (2008).
8. Riddle DR, Sonntag WE, Lichtenwalner RJ. Microvascular plasticity in aging. Ageing Res Rev 2: 149-168 (2003).
9. Fjell AM, Walhovd KB. Structural brain changes in aging: courses, causes and cognitive consequences. Rev Neurosci 21: 187-221 (2010).
10. Raz N, Rodrigue KM, Kennedy KM, Acker JD. Vascular Health and Longitudinal Changes in Brain and Cognition in Middle-Aged and Older Adults. Neuropsychology 21: 149-157 (2007).
11. Jellinger KA. Morphologic diagnosis of vascular dementia--A critical update. J Neurological Sci 270: 1-12 (2008).
12. Fernando MS, O'Brien JT, Perry RH, English P, Forster G, McMeekin W, et al. Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol 30: 385-395 (2004).
13. Fernando MS, Simpson JE, Matthews F, Brayne C, Lewis CE, Barber R, et al. White Matter Lesions in an Unselected Cohort of the Elderly: Molecular Pathology Suggests Origin From Chronic Hypoperfusion Injury. Stroke 37: 1391-1398 (2006).
14. Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 43: 2457-2465 (1993).
15. Mirra SS. The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary. Neurobiol Aging 18: S91-94 (1997).
16. Grudzien A, Shaw P, Weintraub S, Bigio E, Mash DC, Mesulam MM. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging 28: 327-335 (2007).
17. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277: 813-817 (1997).
18. de la Torre JC. Alzheimer Disease as a Vascular Disorder: Nosological Evidence. Stroke 33: 1152-1162 (2002).
19. Goulding JMR, Signorini DF, Chatterjee S, Nicoll JAR, Stewart J, Morris R, et al. Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia. J Neurol Neurosurg Psychiatry 67: 654-657 (1999).
20. Arvanitakis Z, Schneider JA, Wilson RS, Li Y, Arnold SE, Wang Z, et al. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 67: 1960-1965 (2006).
21. Nelson PT, Smith CD, Abner EA, Schmitt FA, Scheff SW, Davis GJ, et al. Human cerebral neuropathology of Type 2 diabetes mellitus. Biochim Biophys Acta 1792(5): 454-69 (2008).
22. Garcia JH. The neuropathology of stroke. Human Pathology 6: 583-598 (1975).
23. Andin U, Gustafson L, Passant U, Brun A. A clinico-pathological study of heart and brain lesions in vascular dementia. Dement Geriatr Cogn Disord 19: 222-228 (2005).
24. Andin U, Passant U, Gustafson L, Englund E. Alzheimer's disease (AD) with and without white matter pathology-clinical identification of concurrent cardiovascular disorders. Archives of Gerontology and Geriatrics 44: 277-286 (2007).
25. Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Neurobiol Aging 21: 57-62 (2000).
26. Yamada M. Risk factors for cerebral amyloid angiopathy in the elderly. Ann NY Acad Sci 977: 37-44 (2002).
27. Sparks DL. Coronary Artery Disease, Hypertension, ApoE, and Cholesterol: A Link to Alzheimer's Disease? Ann NY Acad Sci 826: 128-146 (1997).
28. Beeri MS, Rapp M, Silverman JM, Schmeidler J, Grossman HT, Fallon JT, et al. Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology 66: 1399-1404 (2006).
29. Sparks DL, Scheff SW, Liu H, Landers TM, Coyne CM, Hunsaker JC. Increased incidence of neurofibrillary tangles (NFT) in nondemented individuals with hypertension. J Neurol Sci 131: 162-169 (1995).
30. Irina A, Seppo H, Arto M, Paavo R, Hilkka S. ß-Amyloid Load Is Not Influenced by the Severity of Cardiovascular Disease in Aged and Demented Patients. Stroke 30: 613-618 (1999).
31. Alafuzoff I, Helisalmi S, Mannermaa A, Soininen H. Severity of Cardiovascular Disease, Apolipoprotein E Genotype, and Brain Pathology in Aging and Dementia. Ann NY Acad Sci 903: 244-251 (2000).
32. Brayne C, McCracken C, Matthews FE. Cohort profile: the Medical Research Council Cognitive Function and Ageing Study (CFAS). Int J Epidemiol 35: 1140-1145 (2006).
33. MRC CFAS. MRC CFAS Medical Research Council Cognitive Function and Ageing Study Group: Cognitive function and dementia in six areas of England and Wales: the distribution of MMSE. Psychol Med 28: 319-335 (1998).
34. Saunders PA, Copeland JRM, Dewey ME, Gilmore C, Larkin BA, Phaterpekar H, et al. The Prevalence of Dementia, Depression and Neurosis in Later Life: The Liverpool MRC-ALPHA Study. Int J Epidemiol 22: 838-847 (1993).
35. Matthews FE, Chatfield M, Brayne C. An investigation of whether factors associated with short-term attrition change or persist over ten years: data from the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). BMC Public Health 6: 185 (2006).
36. Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P. Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med 6: e1000180 (2009).
37. Folstein M, Folstein S, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 12: 189-198 (1975).
38. Copeland JR, Dewey ME, Griffiths-Jones HM. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med 16: 89-99 (1986).
39. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, et al. A standarized instrument for the diagnoses of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149: 698-709 (1986).
40. Copeland JRM, Dewey ME. Neuropsychological diagnosis (GMSHAS-AGECAT package). Int Psychogeriatr 3: 43-49 (1991).
41. Copeland J, Dewey M, Saunders P. The epidemology of dementia: GMS-AGECAT studies of prevalence and incidence, including studies in progress. Eur Arch Psychiatry Neurol Sci 240: 212-217 (1991).
42. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C, the Medical Research Council Cognitive Function and Ageing S. Age, Neuropathology, and Dementia. New England Journal of Medicine 360: 2302-2309 (2009).
43. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study MC. Pathological correlates of lateonset dementia in a multicentre, community-based population in England and Wales. Lancet 357: 169-175 (2001).
44. Corser W, Sikorskii A, Olomu A, Stommel M, Proden C, Holmes-Rovner M. Concordance between comorbidity data from patient self-report interviews and medical record documentation. BMC Health Services Research 8: 85 (2008).
45. Simpson CF, Boyd CM, Carlson MC, Griswold ME, Guralnik JM, Fried LP. Agreement between self-report of disease diagnoses and medical record validation in disabled older women: factors that modify agreement. J Am Geriatr Soc 52: 123-127 (2004).
46. Prince M, Acosta D, Chiu H, Scazufca M, Varghese M. Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet 361: 909-917 (2003).
47. Prohovnik I, Perl DP, Davis KL, Libow L, Lesser G, Haroutunian V. Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease. Neurology 66: 49-55 (2006).
48. Liebetrau M, Steen B, Skoog I. Stroke in 85-year-olds: prevalence, incidence, risk factors, and relation to mortality and dementia. Stroke 34: 2617-2622 (2003).
49. de Leeuw FE, de Groot JC, Oudkerk M, Witteman JC, Hofman A, van Gijn J, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 125: 765-772 (2002).
50. Shinkawa A, Ueda K, Kiyohara Y, Kato I, Sueishi K, Tsuneyoshi M, et al. Silent Cerebral Infarction in a Community-Based Autopsy Series in Japan: The Hisayama Study. Stroke 26: 380-385 (1995).
51. Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 109: 813-836 (2002).
52. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 62: 1148-1155 (2004).
53. Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 62: 406-413 (2007).
54. Chui HC, Zarow C, Mack WJ, Ellis WG, Zheng L, Jagust WJ, et al. Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol 60: 677-687 (2006).
55. White L, Small BJ, Petrovitch H, Ross GW, Masaki K, Abbott RD, et al. Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study. J Geriatr Psychiatry Neurol 18: 224-227 (2005).
56. Heitner J, Dickson D. Diabetics do not have increased Alzheimertype pathology compared with age-matched control subjects: A retrospective postmortem immunocytochemical and histofluorescent study. Neurology 49: 1306-1311 (1997).
57. Masuda J, Tanaka K, Ueda K, Omae T. Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. Stroke 19: 205-210 (1988).
58. Peila R, Rodriguez BL, Launer LJ. Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies: The Honolulu-Asia Aging Study. Diabetes 51: 1256-1262 (2002).